A Patient-Centric Approach to the Development of Advanced Therapies
Time: 9:00 am
day: Day One
- Ensuring your organization is patient-centric not only delivers more relevant and impactful patient outcomes, but it also can increase speed, efficiency, and productivity in the development advanced medicines. How do we ensure that patients are always top-of-mind during drug development? How has having a patient-focused mindset made a difference in finding cures for rare genetic orders?
- Hear from Kyle Bryant, Director of rideATAXIA at FARA (Friedreich’s Ataxia Research Alliance), on his perspective as a patient living with a degenerative neuro-muscular disorder and the impact the gene therapy community is making for patients and their families
- Learn how a patient-focused mindset can optimized speed-to-market for the development of gene therapies